Skip to main navigation Skip to search Skip to main content

Engineered virus-like particle-assembled Vegfa-targeting Cas9 ribonucleoprotein treatment alleviates neovascularization in wet age-related macular degeneration

Press/Media

Period2025.10.9

Media coverage

1

Media coverage